Building Muscle and Losing Fat Simultaneously? Your Genes May Be Fighting You.

FTO sits at the intersection of appetite, energy expenditure, and body weight regulation. Under normal conditions, this gene helps your brain interpret satiety signals from your digestive system and adipose tissue. When you’ve eaten enough, FTO activity helps suppress further food intake. It also influences your metabolic rate and how your body allocates calories between storage and expenditure.

Here’s where it gets complicated: the A allele at rs9939609, present in roughly 45% of people with European ancestry, impairs your brain’s ability to sense fullness. People carrying this variant require more food volume to feel satisfied. They also tend to have a stronger preference for high-fat, calorie-dense foods. This isn’t a willpower problem. It’s a neurobiology problem. Your satiety signaling is literally dampened at the genetic level.

During body recomposition, this becomes critical. You’re trying to maintain adequate calories for muscle synthesis while creating enough of a deficit to mobilize fat. If your FTO variant is blunting satiety, you’ll experience constant hunger even in modest deficits, making adherence nearly impossible. You may also unconsciously gravitate toward higher-calorie foods, which derails body composition goals before willpower even enters the equation.

PPARG (peroxisome proliferator-activated receptor gamma) is essentially the master regulator of how your body stores and mobilizes fat. It controls the expression of genes involved in adipogenesis (the creation of new fat cells), fat cell differentiation, and lipid uptake into adipose tissue. Under normal conditions, this gene helps your body sequester excess energy in fat stores, which is metabolically protective. Too much circulating fat is inflammatory and damaging; safe storage in adipose tissue is actually beneficial.

The Pro12 allele, carried by roughly 25% of the population, shifts this system toward very efficient fat storage. Your fat cells are metabolically “sticky.” They accumulate lipids readily and release them slowly, even during exercise or caloric deficits. This can be protective in environments of food scarcity, but during deliberate body recomposition when you’re trying to mobilize fat, you’re fighting against a strong biological drive to store and retain it.

During cutting phases or caloric deficits, people with the Pro12 allele often experience a frustrating plateau. Your body is reluctant to mobilize stored fat despite the caloric deficit. You may lose scale weight initially, but much of that comes from muscle and water before fat begins to mobilize. Meanwhile, your strength drops faster than it should because your body is preferentially sparing fat stores and catabolizing muscle instead.

ADRB2 encodes the beta-2 adrenergic receptor, which sits on the surface of fat cells and responds to catecholamine hormones like epinephrine and norepinephrine. During exercise, your sympathetic nervous system floods these hormones to trigger lipolysis, the breakdown and release of stored fat. ADRB2 is the lock; catecholamines are the key. When the receptor works efficiently, your fat cells release fatty acids into circulation for energy. When it doesn’t, fat mobilization is impaired despite high exercise-induced catecholamine levels.

The Gln27Glu and Arg16Gly variants, carried by roughly 40% of the population, reduce the responsiveness of fat cells to catecholamine signals. Your fat cells are metabolically “deaf” to the exercise signal. You can do high-intensity interval training, cardio, or resistance work and still mobilize fat less efficiently than someone with the more sensitive version. The hormonal signal is loud; your fat cells just aren’t listening as well.

This shows up as a specific problem during body recomposition: your cardio and training volumes might be adequate, but fat isn’t releasing from storage the way it should. You’ll notice your energy seems lower during training. Your body is struggling to mobilize enough fuel from fat stores, so you fatigue faster. Meanwhile, you’re creating a caloric deficit that should be mobilizing more fat, but instead your body preferentially breaks down muscle for amino acids.

ACTN3 encodes alpha-actinin-3, a structural protein in fast-twitch muscle fibers that contributes to explosive force production. Fast-twitch fibers have higher growth potential in response to resistance training and contribute more to muscle hypertrophy. Slow-twitch fibers are more oxidative and fatigue-resistant but have lower hypertrophic potential. Your ACTN3 genotype influences which fiber type population dominates your muscles.

Roughly 18% of people with European ancestry carry the X/X (null) genotype, meaning they produce no functional ACTN3 at all. These individuals have virtually no fast-twitch fibers with functional alpha-actinin-3, which reduces their explosive power capacity. However, this often comes with a compensatory shift toward an enhanced endurance phenotype. They tend to have better oxidative capacity and fatigue resistance. People with at least one R allele have functional ACTN3 and better explosive power potential, though they may tire more quickly.

For body recomposition, this matters because muscle hypertrophy responds best to heavy resistance training with sufficient volume. If you’re X/X (null), your muscle-building potential is real but follows a different trajectory. You may build muscle more slowly with traditional hypertrophy programming (heavy weight, lower reps), but you might respond exceptionally well to higher-rep, higher-volume approaches that engage oxidative metabolism. Your recomposition will likely look different, with potentially slower muscle gain but potentially superior fat loss due to endurance capacity.

LEPR encodes the leptin receptor, which sits in your hypothalamus and receives signals from leptin, a hormone released by fat cells. Leptin essentially tells your brain, “We have adequate energy stored; you can stop seeking food and you can spend energy freely.” It’s the master satiety signal. When leptin signaling works normally, your appetite and energy expenditure adjust based on your body’s energy status. When leptin signaling is impaired, your brain doesn’t receive the “all clear” signal even when fat stores are adequate.

Variants in LEPR, present in roughly 20-30% of the population, impair your brain’s ability to read leptin signals, even though your leptin levels might be completely normal. Your adipose tissue is sending the signal, but your hypothalamus isn’t receiving it properly. This creates a state where your brain thinks you’re in energy deficit even if you’re not, which drives up appetite, reduces energy expenditure, and makes your body preferentially store fat and spare energy.

During body recomposition in a caloric deficit, LEPR variants make adherence extraordinarily difficult. You experience constant hunger and low energy despite objectively adequate calories. Your metabolic rate also tends to drop more aggressively in response to caloric restriction, making fat mobilization slower. You may also experience metabolic adaptation faster than others on the same protocol.

VDR encodes the vitamin D receptor, which is expressed in muscle cells and bone cells and mediates the effects of active vitamin D on calcium handling, muscle protein synthesis, and muscle fiber growth. When vitamin D binds to VDR, it triggers a cascade of gene expression that supports muscle growth, strength gains, and recovery from training. Without adequate VDR function, muscle cells are deaf to vitamin D’s anabolic signals even if your serum vitamin D levels are adequate.

VDR polymorphisms, particularly the BsmI and FokI variants present in 30-50% of populations depending on ancestry, reduce your muscle cells’ responsiveness to vitamin D signaling. Your cells require higher vitamin D concentrations to trigger the same muscle-building effects. This impairs your body’s ability to synthesize new muscle protein in response to resistance training and slows recovery between workouts.

During body recomposition, VDR variants become a practical bottleneck for muscle synthesis. You can train hard and eat enough protein, but your muscle cells aren’t responding as efficiently to the anabolic stimulus. Recovery is slower, strength gains plateau earlier, and muscle hypertrophy lags behind what you’d expect from your training volume. You fatigue faster and require longer recovery between hard sessions.